Exploring the Constituents and Mechanisms of Polygonum multiflorum Thunb. in Mitigating Ischemic Stroke: A Network Pharmacology and Molecular Docking Study
- PMID: 38623977
- DOI: 10.2174/0113862073285988240229081558
Exploring the Constituents and Mechanisms of Polygonum multiflorum Thunb. in Mitigating Ischemic Stroke: A Network Pharmacology and Molecular Docking Study
Abstract
Backgound: Polygonum multiflorum Thunb. (PMT) has shown promise in exerting cerebrovascular protective effects, and its potential for treating ischemic stroke (IS) has garnered attention. However, the lack of clarity regarding its chemical constituents and mechanisms has significantly hindered its clinical application.
Methods: In this study, we employed network pharmacology and molecular docking techniques for the first time to elucidate the potential compounds and targets of PMT in treating IS. The databases CTD, DrugBank, DisGeNET, GeneCards, OMIM, TTD, PGKB, NCBI, TCMIP, CNKI, PubMed, ZINC, STITCH, BATMAN, ETCM and Swiss provided information on targets related to IS and components of PMT, along with their associated targets. We constructed "compoundtarget" and protein-protein interaction (PPI) networks sourced from the STRING database using the Cytoscape software. Gene Ontology (GO) enrichment analysis and KEGG pathway analysis were conducted using the DAVID database. Molecular docking between core targets and active compounds was conducted using Autodock4 software. Experiments were performed in an oxygen- glucose deprivation and reperfusion (OGD/R) model to validate the anti-IS activity of compounds isolated from PMT preliminarily. Network pharmacological analysis revealed 16 core compounds, including resveratrol, polydatin, TSG, ω-hydroxyemodin, emodin anthrone, tricin, moupinamide, and others, along with 11 high-degree targets, such as PTGS1, PTGS2, ADORA1, ADORA2, CA1, EGFR, ESR1, ESR2, SRC, MMP3 and MMP9.
Results: GO and KEGG enrichment analyses revealed the involvement of HIF-1, Akt signaling pathway and energy metabolism-related signaling pathways. Molecular docking results emphasized eight key compounds and confirmed their interactions with corresponding targets. In vitro OGD/R model experiments identified TSG and tricin as the primary active substances within PMT for its anti-stroke activity.
Conclusion: This study contributes new insights into the potential development of PMT for stroke prevention and treatment.
Keywords: Polygonum multiflorum Thunb.; ischemic stroke; molecular docking; network pharmacology; oxygen-glucose deprivation and reperfusion (OGD/R); protein-protein interaction (PPI)..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Mechanism of Ligusticum wallichii-Borneol in the Treatment of Cerebral Ischemic Stroke in Rats Based On Network Pharmacology, Molecular Docking, and Experimental Verification.Chem Biodivers. 2025 May;22(5):e202401893. doi: 10.1002/cbdv.202401893. Epub 2025 Jan 13. Chem Biodivers. 2025. PMID: 39714965
-
Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke.J Ethnopharmacol. 2023 Aug 10;312:116507. doi: 10.1016/j.jep.2023.116507. Epub 2023 Apr 18. J Ethnopharmacol. 2023. PMID: 37080367
-
Exploring the pharmacological components and effective mechanism of Mori Folium against periodontitis using network pharmacology and molecular docking.Arch Oral Biol. 2022 Jul;139:105391. doi: 10.1016/j.archoralbio.2022.105391. Epub 2022 Mar 21. Arch Oral Biol. 2022. PMID: 35430443
-
Exploring the mechanism of action of Yiyi Fuzi Baijiang powder in colorectal cancer based on network pharmacology and molecular docking studies.Biotechnol Genet Eng Rev. 2023 Oct;39(2):1107-1127. doi: 10.1080/02648725.2023.2167765. Epub 2023 Feb 3. Biotechnol Genet Eng Rev. 2023. PMID: 36735641 Review.
-
Exploring the antitumor potential of cucurbitacin B in hepatocellular carcinoma through network pharmacology, molecular docking, and molecular dynamics simulations.Naunyn Schmiedebergs Arch Pharmacol. 2025 May 21. doi: 10.1007/s00210-025-04273-x. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40397117 Review.
References
-
- Tsao C.W.; Aday A.W.; Almarzooq Z.I.; Alonso A.; Beaton A.Z.; Bittencourt M.S.; Boehme A.K.; Buxton A.E.; Carson A.P.; Commodore-Mensah Y.; Elkind M.S.V.; Evenson K.R.; Eze-Nliam C.; Ferguson J.F.; Generoso G.; Ho J.E.; Kalani R.; Khan S.S.; Kissela B.M.; Knutson K.L.; Levine D.A.; Lewis T.T.; Liu J.; Loop M.S.; Ma J.; Mussolino M.E.; Navaneethan S.D.; Perak A.M.; Poudel R.; Rezk-Hanna M.; Roth G.A.; Schroeder E.B.; Shah S.H.; Thacker E.L.; VanWagner L.B.; Virani S.S.; Voecks J.H.; Wang N.Y.; Yaffe K.; Martin S.S.; Heart disease and stroke statistics—2022 update: A report from the american heart association. Circulation 2022,145(8),e153-e639 - DOI - PubMed
MeSH terms
Substances
Grants and funding
- 2022YFC2105202/National Key Research and Development Program of Ministry of Science and Technology
- CJ20220217/Changzhou Sci & Tech Program
- ZMF23020004, ZMF23020013/Initial Research Funding of Changzhou University
- QZX23020109, QZX23020226/Extracurricular Innovation and Entrepreneurship Fund Project for College Students of Changzhou University
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous